The protein tyrosine kinase inhibitor PTK is a group of enzymes that catalyze the transfer of a phosphate group on ATP to many important protein tyrosine residues, phosphorylating their residues, and activating various substrate enzymes. A series of reactions affect cell growth, proliferation and differentiation. To date, many PTK inhibitors have been shown to have anticancer activity, some of which can induce leukemia cell differentiation; PTK inhibitors have also achieved some promising results in combination with other anticancer drugs for the treatment of cancer. (1) Receptor tyrosine kinase (RTK) is a major family of receptors on the cell surface. All RTKs consist of three components: (1) an extracellular domain containing a ligand binding site, (2) a single transmembrane hydrophobic alpha helix region, and (3) a tyrosine kinase-containing cell. Internal domain. More than 50 different RTKs have been discovered, which can be divided into 6 subfamilies according to their structure (Fig. 32-15). Its extracellular ligand is a soluble or membrane-bound polypeptide or protein hormone, including insulin and various growth factors, mainly epidermal growth factor (EGF), platelet growth factor (PDGF), macrophage colony-stimulating factor ( M-CSF), insulin, insulin-like growth factor-1 (IGF-1), hepatocyte growth factor (HGF), nerve growth factor (NGF), and vascular endothelial growth factor (VEGF). (2) Activation of the receptor tyrosine kinase is a rather complex process, first requiring ligand-mediated dimerization to form homologous or heterologous dimers by dimerization. The dimers phosphorylate tyrosine residues in the intracellular region of the receptor, ie, autophosphorylation of the receptor. Ligand-mediated receptor dimerization (oligomerization) has been found to be a common mechanism for activating transmembrane enzyme-coupled receptors. For different types of ligands, the specific mechanism of action can be slightly different: some ligands are themselves dimers (such as PDGF, etc.), they contain two receptor-binding surfaces that allow the two receptors to crosslink. Together; some ligands are haplotypes (such as hGH), but they have two different sites on their surface that can be contacted with two receptor molecules to form a 1:2 ratio of ligand-receptor complexes. In addition, fibroblast growth factor itself is a monomer that does not induce dimerization of its receptor, and it is required to form a multivalent complex with heparin sulfate proteoglycan to bind two or more receptors. (3) Imatinib mesylate is a novel tyrosine kinase inhibitor and a derivative of phenylpyrimidine. About 95% of patients with chronic myeloid leukemia (CML) are positive for Ph1 chromosome, that is, the proto-oncogene ABL of chromosome 9 is ectopic to the oncogene of chromosome 22 called the breakpoint clustering region (BCR). The two genes are recombined to produce the fusion protein p-210. Compared with the normal C-ABL protein p-150, p-210 has high tyrosine kinase activity, which can stimulate leukocyte proliferation and lead to leukemia. The drug can strongly inhibit the activity of ABL tyrosine kinase in vitro and in vivo, specifically inhibit the expression of ABL and the proliferation of BCR-ABL cells, and thus can be used for the treatment of CML. In addition, the drug inhibits tyrosine kinases of platelet-derived growth factor (PDGF) and stem cell factor (SCF) receptors, and inhibits PDGF and SCF-mediated biochemical reactions, but does not affect other stimulating factors such as epidermal growth factor. Signaling. (4) Tyrosine kinase receptor pathway: The tyrosine kinase receptor pathway is one of the most important pathways in cell signaling networks. Most growth factor signals perform regulatory functions through this pathway. The growth factor receptor itself has tyrosine kinase activity or acts by binding to a membrane tyrosine protein kinase. The tyrosine protein kinase consists of four major components: the outer side of the cell is the ligand recognition binding site, followed by a transmembrane structure, the intracellular is the catalytic site of tyrosine protein kinase, and the regulatory site is located at the carboxy terminus. Peptide chain tail. When the agonist binds to the extracellular recognition site, the membrane tyrosine protein kinase is activated, autophosphorylated, and then alters the activation of the effector. Various structural changes, some of which are only a few amino acid residues in key regions, can lead to the production of uncontrolled tyrosine protein kinase oncogenes. (5) Receptor tyrosine protein kinase: Tyrosine protein kinase (TPK) functions by phosphorylating a tyrosine residue in a substrate protein, and has both a receptor type and a non-receptor type. The receptors themselves have tyrosine protein kinase activity, and their ligands are mostly cell growth factors such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (EGF), fibroblast growth factor (FGF) and the like. Upon binding of the ligand to the receptor, cell growth, differentiation and metabolism are regulated by phosphorylation of the receptor itself and substrate protein tyrosine residues and the enzymatic cascade initiated thereby. Such receptor molecules can be divided into three structural regions, namely an extracellular ligand binding region, a tyrosine kinase active region in the cell, and a transmembrane region connecting the two structural regions. Such receptors not only have tyrosine protein activating properties, but also the receptor itself has a phosphorylation site of a tyrosine residue, that is, tyrosine phosphorylation can occur by itself. When a ligand binds to a receptor, receptor dimerization can occur, activating the tyrosinase activity of the receptor, and phosphorylating its own tyrosine residue, which in turn causes phosphorylation of its own tyrosine. Its conformation changes to become the recognition site of the tyrosine protein kinase substrate, which is recognized by the downstream signaling molecules, thereby promoting the signal transmission and amplification step by step through the cascade phosphorylation reaction. (6) Protein tyrosine kinase-associated receptors: These receptors do not themselves have tyrosine kinase activity, but their cytoplasmic side contains a site for protein tyrosine kinase activity when the receptor binds to a ligand. The JAK-like protein tyrosine kinase can be combined and activated to initiate intracellular signal transduction.


Amino compound >
Oxy-containing amino compound Cycloalkylamines, aromatic monoamines, aromatic polyamines and derivatives and salts thereof Acyclic monoamines, polyamines and their derivatives and salts Amide compound Sulfonic acid amino compound
Alcohols, phenols, phenolic compounds and derivatives >
2-cycloalcohol Halogenated, sulfonated, nitrated or nitrosated derivatives of alcohols Extremely halogenated, sulfonated, nitrated or nitrosated derivatives of phenols Phenol and its halogenated, sulfonated, nitrated or nitrosated derivatives Acyclic alcohol
Nitrogen-containing compound
Nitrile compound
Organic derivative of hydrazine or hydrazine
Terpenoid
Ether compounds and their derivatives >
Ether, ether alcohol Halogenation, sulfonation, nitration or nitrosation of ethers, ether alcohols, ether phenols
Aldehyde
Carboxylic compounds and derivatives >
Cyclic carboxylic acid Halogenation, sulfonation, nitration or nitrosation of carboxylic acids Halogenation, sulfonation, nitration or nitration of carboxylic anhydrides Carboxylic acid halide Carboxylic esters and their derivatives Salt of carboxylic acid ester and its derivatives Acyclic carboxylic acid
Hydrocarbon compounds and their derivatives >
Aromatic hydrocarbon Cyclic hydrocarbon Hydrocarbon sulfonate Hydrocarbon halide Hydrocarbon nitrite Acyclic hydrocarbon
Ketone compound
Alkyl ureas and their derivatives and salts
Inorganic acid ester
Heterocyclic compound
Diazo, azo or azo compound
Organosilicon compound
Organometallic compound >
Organic palladium Organic germanium, cobalt, strontium, barium, gallium, germanium, germanium, germanium, germanium, etc. Organic calcium Zirconium Organic potassium Organic Organic lithium Organic Organic aluminum Organotin Organic manganese Organic sodium Organic nickel Organic titanium Organic iron Organic copper Organotin Organic zinc Organic Organic Organic germanium, mercury, silver, platinum, etc. Organic germanium, antimony, bismuth, tungsten, antimony, bismuth, lead, vanadium, molybdenum, chromium, antimony, etc.
Organic sulfur compound
Organic phosphine compound
Organometallic salt
Organic fluorine compound >
Fluorobenzoic acid series Fluorobenzonitrile series Fluorobenzaldehyde series Fluorobenzyl alcohol series Fluoroanisole series Fluoroaniline series Fluorophenylacetic acid series Fluorophenol series Fluorobenzoic acid series Fluoronitrobenzene series Fluoropyridine series Potassium fluoroborate series Fluorobenzyl alcohol series Fluorotoluene series Fluorine red series Fluoroethane series Fluoropropane series
Respiratory medication >
Asthma Other respiratory medications Peony Antitussive
Hormone and endocrine-regulating drugs >
Birth control pills Pituitary hormone Estrogen and progestogen drugs Adrenocorticotropic drugs Gonadotropin Thyroid hormone and antithyroid drugs other Prostaglandins Adrenal corticosteroids Androgen and anabolic hormone drugs Pancreatic hormones and other blood sugar regulating drugs Treatment of male erectile dysfunction drugs
Antipyretic analgesics >
Non-steroidal anti-inflammatory drugs Antipyretic and analgesic Anti-migraine drug Anti-gout medicine Analgesic
Antiallergic >
Allergic reaction medium blocker Antihistamine
Antiparasitic drug >
Anti-amebiasis and anti-trichomoniasis drugs Antimalarial Resistance to filariasis and anti-leishmaniasis Anti-fungal medicine Anthelmintic Antiprotozoal Anthelmintic
Antibiotics >
Beta-lactamase inhibitor Aminoglycoside Macrolide drug Peptide Polyene Rifamycin Lincosamide Other antibiotics Penicillin Tetracycline Cephalosporin Amide alcohol Agricultural antibiotics
Antineoplastic agents >
Hormone antineoplastic agents Antimetabolite antineoplastic Antibiotic antineoplastic agents Anti-tumor adjuvant Other antineoplastic agents Natural source antineoplastic agents Alkylating agent Tinic antineoplastic agents Idiopathic pulmonary fibrosis (IPF) treatment
Anesthetic Agents >
Skeletal muscle relaxant Local anesthetics General anesthetics
Urinary system medication >
Diuretic Diabetes insipidus medication Other urinary system medication Dehydrated medicine
Other chemicals >
other Health and epidemic prevention drugs
Synthetic anti-infective drugs >
Sulfonamides and synergists Antiviral drugs Anti-tuberculosis leprosy Antihelium drug Antifungal drugs Quinolone Natural source anti-infectives Disinfectant antiseptic Nitrofuran
Nervous system medication >
2 sedative and hypnotics Antiepileptic and anticonvulsant Anxiolytic Antipsychotic Antidepressant, manic Anti-shock palsy Brain metabolism regulating drug Cholinergic Other nervous system medication Central stimulant Parkinson's syndrome
Water, electrolyte and acid-base balance regulator >
Electrolyte balance regulator Glucose drug Acid-base balance regulator
Vitamins and minerals >
Trace elements and mineral drugs Vitamin AD drugs Vitamin B drugs Vitamin C drugs Nutritional health medicine
Digestive system medication >
Liver disease medication Acid and gastric mucosal protective drugs Biliary medicine Other digestive system medication Appetite suppressant and other diet pills Gastrointestinal drug Gastrointestinal expectorant Laxative antidiarrheal Inhibition of gastric acid secretion Antiemetic emetic Digestive drug
Blood system medication >
Leukocyte proliferative drug Platelet proliferative drug Anticoagulant and antiplatelet drugs Anti-anemia drug Blood volume expander Hemostatic drug
Circulatory system medication >
Regulating blood lipids Prevention and treatment of angina pectoris Calcium channel blocker Anti-congestive heart failure medicine Antihypertensive drug Antiarrhythmic drug Anti-shock vasoactive drug Other circulatory system medication Angiotensin converting enzyme and receptor inhibitor Peripheral vasodilator Beta-adrenergic receptor blocker Treatment of chronic cardiac insufficiency Anti-atherosclerosis
Diagnostic medication >
Organ function test agent Image inspection medication
Special medicine >
Radioisotope Antidote Stomatology medication Dermatology medication Surgical medication Ophthalmic medication
Drugs that affect tissue metabolism
Feed drug additive
Anti-stress drug
Immune function drug >
Immunomodulatory drug Immunosuppressive drug
Veterinary drug raw materials
Inhibitor
Common amino acids and protein drugs
Nucleic acid drug
Enzymes and coenzymes
Inhibitor >
Immune inhibitor Protein tyrosine kinase Neuronal Signaling PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones G protein coupled receptor(GPCR & G Protein) Transmembrane Transporters Tyrosine protein kinase/signal transducer and transcriptional activator inhibitor (JAK/STAT) TGF-beta/Smad signaling pathway inhibitor (TGF-beta/Smad) Stem Cells & Wnt Signaling Paths (Stem Cells & Wnt) Nuclear transcription factor (NF-κB) Ubiquitin inhibitor Microbiology Autophagy lysosome (Autophagy)
Biological response modifier
Fatty drug
Amino acids and their derivatives >
Arginine derivatives Asparagine derivatives Aspartic acid derivative Cysteine derivative Glutamine derivative Glutamic acid derivative Glycine derivatives Histidine derivative Isoleucine derivative Leucine derivative Lysine derivative Methionine derivatives Phenylalanine derivatives Proline derivatives Serine derivative Threonine derivative Tryptophan derivatives Tyrosine derivatives Proline derivatives Alanine derivatives Methionine derivatives BOC-amino acid Cbz-amino acid FMOC-amino acid --amino acid Other protected amino acids Amino alcohol derivative Amino acid salt Ester amino acid Other amino acid derivatives Natural amino acids and their derivatives
Carbohydrate >
Monosaccharide Oligosaccharide Polysaccharide Double sugar
Biochemical reagent >
Biological dye Acid-base indicator Adjuvant
Nucleoside drugs >
Nucleoside intermediate Deoxynucleotides and their analogues Nucleotides and their analogues
Condensing agent
Peptide
Natural product
Plant extracts
Chinese herbal medicine ingredients
Microbiological reagent
Protein research
antibody >
Antibody Enzyme secondary antibody Apoptosis and autophagy Cell metabolism Chromatin / epigenetic / cell cycle Cytoskeleton/extracellular matrix MAPK and PI3K/Akt pathway Neuroscience Immunity and inflammation PKC, calcium ion and lipid signaling pathway Stem cells, development and differentiation Protein translation, folding and degradation Other categories of primary antibodies
  • CAS Number: 850879-09-3
  • MF: C23H21N5O3S
  • MW: 447.509
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 649.5±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 346.6±34.3 °C
  • CAS Number: 1022150-57-7
  • MF: C18H13N7S
  • MW: 359.408
  • Catalog:Protein tyrosine kinase
  • Density: 1.5±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1185763-69-2
  • MF: C20H16N6
  • MW: 340.381
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1225451-84-2
  • MF: C13H12N4O2S2
  • MW: 320.390
  • Catalog:Protein tyrosine kinase
  • Density: 1.5±0.1 g/cm3
  • Boiling Point: 522.4±60.0 °C at 760 mmHg
  • Melting Point: 193 °C
  • Flash Point: 269.7±32.9 °C
  • CAS Number: 1225278-16-9
  • MF: C26H21F2N5O3
  • MW: 489.47300
  • Catalog:Protein tyrosine kinase
  • Density: 1.40±0.1 g/cm3 (20 ºC 760 Torr)
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 728033-96-3
  • MF: C22H16F3N3O2S
  • MW: 443.441
  • Catalog:Protein tyrosine kinase
  • Density: 1.5±0.1 g/cm3
  • Boiling Point: 517.4±50.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 266.7±30.1 °C
  • CAS Number: 1001350-96-4
  • MF: C23H24FN9O
  • MW: 461.495
  • Catalog:Protein tyrosine kinase
  • Density: 1.6±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 610798-31-7
  • MF: C22H21N3O4
  • MW: 391.420
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 581.3±50.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 305.3±30.1 °C
  • CAS Number: 504433-23-2
  • MF: C17H13N3O
  • MW: 275.305
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 568.0±50.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 297.3±30.1 °C
  • CAS Number: 153436-53-4
  • MF: C16H14ClN3O2
  • MW: 315.754
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 458.5±45.0 °C at 760 mmHg
  • Melting Point: 247 °C(dec.)
  • Flash Point: 231.1±28.7 °C
  • CAS Number: 1037624-75-1
  • MF: C30H34N8
  • MW: 506.645
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 799.6±70.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 437.4±35.7 °C
  • CAS Number: 194423-06-8
  • MF: C18H13BrN4O
  • MW: 381.226
  • Catalog:Protein tyrosine kinase
  • Density: 1.6±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: 276 °C
  • Flash Point: N/A
  • CAS Number: 228559-41-9
  • MF: C24H18F3N3O4
  • MW: 469.413
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 497.1±45.0 °C at 760 mmHg
  • Melting Point: 239℃
  • Flash Point: 254.4±28.7 °C
  • CAS Number: 497839-62-0
  • MF: C27H32N6
  • MW: 440.583
  • Catalog:Protein tyrosine kinase
  • Density: 1.2±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: 247 °C
  • Flash Point: N/A
  • CAS Number: 343787-29-1
  • MF: C24H27N5O2
  • MW: 417.504
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 656.3±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 350.7±34.3 °C
  • CAS Number: 1056634-68-4
  • MF: C23H22N6O2
  • MW: 414.460
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 690206-97-4
  • MF: C16H13ClFN3O2
  • MW: 333.745
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 434.1±45.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 216.4±28.7 °C
  • CAS Number: 1493764-08-1
  • MF: C25H33N7O2
  • MW: 463.575
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 849217-68-1
  • MF: C28H24FN3O5
  • MW: 501.506
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 758.1±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 412.3±32.9 °C
  • CAS Number: 1110813-31-4
  • MF: C24H25ClFN5O2
  • MW: 469.939
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 665.7±55.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 356.4±31.5 °C
  • CAS Number: 848942-61-0
  • MF: C23H25ClFN5O3
  • MW: 473.928
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 632.8±55.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 336.5±31.5 °C
  • CAS Number: 1116235-97-2
  • MF: C27H29FN8O3
  • MW: 532.569
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 957054-33-0
  • MF: C25H35N7O9S4
  • MW: 705.847
  • Catalog:Protein tyrosine kinase
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: >280°C (dec.)
  • Flash Point: N/A
  • CAS Number: 1097917-15-1
  • MF: C29H40N8O3S
  • MW: 580.745
  • Catalog:Protein tyrosine kinase
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 794.3±70.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 434.2±35.7 °C
  • CAS Number: 477575-56-7
  • MF: C32H34Cl2N4O4S
  • MW: 641.608
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 890.2±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 492.2±34.3 °C
  • CAS Number: 189224-48-4
  • MF: C13H14N2O
  • MW: 214.263
  • Catalog:Protein tyrosine kinase
  • Density: 1.2±0.1 g/cm3
  • Boiling Point: 428.1±34.0 °C at 760 mmHg
  • Melting Point: 137-139ºC
  • Flash Point: 154.4±15.9 °C
  • CAS Number: 1140909-48-3
  • MF: C32H30FN3O10
  • MW: 635.593
  • Catalog:Protein tyrosine kinase
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 212141-51-0
  • MF: C20H17Cl3N4
  • MW: 383.274
  • Catalog:Protein tyrosine kinase
  • Density: N/A
  • Boiling Point: 587.8ºC at760mmHg
  • Melting Point: 268-2700ºC
  • Flash Point: 309.3ºC
  • CAS Number: 1001917-37-8
  • MF: C25H21N5O3S
  • MW: 471.53100
  • Catalog:Protein tyrosine kinase
  • Density: 1.39
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1214265-57-2
  • MF: C24H25ClN6OS
  • MW: 481.013
  • Catalog:Protein tyrosine kinase
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A